This page carries two documents. Part I is our Privacy and Cookie Notice. Part II is our Legal Notes, which are the terms on which we make this website available. Each stands on its own and each is incorporated into the other by reference.
Part I - Privacy and Cookie Notice
This privacy and cookie notice is provided by BrainStorm Cell Therapeutics Inc., a Delaware corporation, and its subsidiaries and affiliates (together “BrainStorm”, “we”, “us” and “our”). It explains how we handle personal data collected through brainstorm-cell.com and any successor address (the “Site”), and the choices available to you in relation to that data.
1. Scope of this Notice
This notice applies to the processing of personal data that arises through the Site. Where we provide a separate or supplemental notice for a particular activity, that notice governs the activity and this one applies only so far as it does not conflict.
a. Visitors to the Site. Technical and usage data is generated whenever the Site is accessed, whether or not you identify yourself. This is described in section 4.
b. People who contact us. Where you complete a form on the Site, or write to an address published on it, we process the identifying and contact details you supply and the content of your message.
c. Subscribers to company communications. Where you ask to receive press releases, program updates or event notifications, we process the address you supply and your subscription preferences.
d. Applicants for employment. Where you send us a resume or apply for a role, we process the information you provide for the purposes of recruitment. A separate applicant notice may be provided at the point of application, and where it is, it governs.
e. Investors, analysts and journalists. Where you contact us in one of those capacities, we process your identifying and contact details, your organization, and our correspondence with you.
f. Matters outside this notice. This notice does not apply to personal data processed in connection with participation in a clinical trial, which is governed by the informed consent document executed with the study site and by the trial protocol; to adverse event, product quality or safety reporting, which is handled under our pharmacovigilance procedures; or to any third-party website, including our investor relations site and our social media profiles, each of which is governed by its own notice.
2. Sensitive Information and Clinical Trials
The Site is provided for information only. It offers no treatment, sells nothing, and is not a route to therapy. It exists so that patients, caregivers, clinicians, investors, journalists and other interested persons may read about our research.
We do not accept medical records or protected health information through the Site. It is not a secure channel for such information and it is not subject to the Health Insurance Portability and Accountability Act. Please do not enter medical records, diagnoses, test results, health details or other private personal information concerning yourself or any other person into any form or message on the Site.
Clinical trials are conducted within a tightly regulated framework. Trial data, adverse event reports and product complaints are collected only through the official monitored channels of the trial itself, and the Site is not one of them. If you need to raise a matter concerning a trial, please speak to your study site. If you need to discuss a medical matter, please speak to your physician. If you are uncertain where a matter should be directed, ask us and we will identify the correct route without requesting any details from you.
Where health information is nonetheless submitted to us, we will handle it in accordance with this notice and applicable law, and we may be required to report it to a health authority.
If you are a healthcare professional or an institutional healthcare provider, you are responsible for obtaining any authorization, consent or other permission required by law from your patients before providing their personal data to us, and by submitting such data you represent to us that you have obtained it.
3. How We Use Your Information
We process personal data on the following bases. Where the EU or UK General Data Protection Regulation applies to a given processing operation, the basis identified below is the legal basis relied upon.
a. Contract. To take steps at your request before entering into a contract and to perform one, including registering you for an event, processing an application for employment, and administering an agreement to which you are a party.
b. Legal obligation. To comply with obligations to which we are subject, including obligations arising under the securities laws applicable to us as a company with publicly traded securities; pharmacovigilance, safety reporting and product quality requirements; tax, accounting and record-keeping requirements; and lawful requests from regulators, courts, law enforcement and other competent authorities. Where you contact us about a possible adverse event or product quality issue, we may use the information you provide in a report to the U.S. Food and Drug Administration or another competent authority.
c. Legitimate interests. To respond to and follow up on inquiries; to provide information about our research, clinical development and company activities to those who have requested it or who have a professional interest in it; to operate, maintain, secure and improve the Site and to understand how it is used; to communicate with shareholders, analysts and prospective investors; to conduct recruitment; to detect, prevent and investigate fraud, abuse, security incidents and breaches of these Legal Notes; and to establish, exercise or defend legal claims. Where we rely on legitimate interests we have considered them against your interests, rights and freedoms.
d. Consent. To send marketing or subscription communications where consent is required, and to set cookies other than those that are strictly necessary. Consent may be withdrawn at any time, without affecting the lawfulness of processing carried out before withdrawal.
We may aggregate or de-identify personal data so that it no longer identifies any individual and use and disclose it for any lawful purpose. We do not use personal data collected through the Site for automated decision-making producing legal or similarly significant effects.
4. Information We Collect
a. Information you provide. Identifying and contact details, such as name, email address, postal address and telephone number; professional details, such as organization, role and area of interest; the content of your communications with us; your subscription preferences; and any information you choose to include in an application for employment.
b. Information collected automatically. Technical and device data, such as IP address, browser type and version, operating system, device characteristics, language setting and referring page; usage data, such as the pages viewed, the time and duration of the visit, the links followed and the files downloaded; and server log data recorded by our hosting provider in the ordinary course of serving the Site and protecting it against abuse. Some of this data is collected through the technologies described in section 5.
c. Information from other sources. We may receive personal data from public registers and databases, professional and industry sources, social media platforms where you interact with us, event organizers, recruitment platforms, our service providers, and our professional advisors.
5. Cookies and Related Tracking Technologies
We and our service providers may use cookies, pixels, web beacons, tags, software development kits, local storage and similar technologies (together, “cookies”) on the Site. A cookie is a small file placed on your device that allows a website to recognize that device on a subsequent visit.
We group these technologies into six categories.
- Category 1: Strictly Necessary Cookies. Required to deliver the Site and to keep it secure. They support functions such as page delivery, load balancing, security, and recording your cookie preferences. The Site cannot be provided properly without them, and they do not require your consent.
- Category 2: Performance Cookies. Collect information about how the Site is found and used - which pages are viewed, how long visitors remain, and where errors occur - so that we may improve it. Information collected by these cookies is used in aggregate.
- Category 3: Functionality Cookies. Record choices you make, such as language or region, so that the Site may be presented in a manner suited to you.
- Category 4: Social Media Cookies. Set by social media platforms where content from those platforms is embedded in the Site or where you use a sharing feature. They enable that functionality and may allow the platform to record your interaction with it.
- Category 5: Advertising Cookies. May be used to measure the effectiveness of our communications and campaigns and, where applicable, to deliver relevant content on the Site or elsewhere. Cookies in this category may involve disclosure of information to advertising and analytics partners.
- Category 6: Email Tracking. Where we send communications you have asked to receive, those messages may contain technologies that record whether the message was opened and whether links within it were followed, so that we may understand whether our communications are useful.
Which categories are in use. Which of these categories operates on the Site at any given time depends upon how the Site is configured at that time. Where the law requires your consent before a cookie other than a strictly necessary one is set, we will obtain that consent before setting it, and you will be able to see the categories in use and to change your choices through the cookie preferences control on the Site. Where no cookie preferences control is displayed on the Site, only strictly necessary cookies are in use.
Third parties. Where cookies in categories 2 to 6 operate, they may be placed by third-party providers of analytics, social media, advertising, video and email services. Those providers process the information they receive under their own notices.
Managing these technologies. In addition to the cookie preferences control, most browsers allow cookies to be blocked or deleted through their settings. Blocking cookies may affect the operation of the Site.
Do Not Track and universal opt-out signals. There is no common industry standard governing the interpretation of browser “Do Not Track” signals, and the Site does not respond to them. Where the law so requires, we treat a recognized universal opt-out mechanism, such as Global Privacy Control, as a valid request to opt out of the sale or sharing of personal data and of targeted advertising, to the extent that we engage in those activities.
6. Sharing Your Personal Data
We disclose personal data to the following categories of recipient:
- Our affiliates and subsidiaries, for the purposes described in this notice.
- Service providers and processors acting on our instructions and not permitted to use the data for their own purposes. These fall within the following categories: website hosting, content delivery and infrastructure; email delivery; forms, customer relationship management and marketing platforms; analytics and website performance measurement; investor relations, webcast and event platforms; recruitment and applicant tracking; document management and storage; security, fraud prevention and information technology support; and professional advisors, including legal, accounting and audit.
- Regulators, courts, law enforcement and other competent authorities, where required or permitted by law, including safety reports made to the U.S. Food and Drug Administration and other health authorities.
- Advisors and counterparties, in connection with a merger, acquisition, financing, reorganization or sale of assets, in which case the recipient is bound to treat the data consistently with this notice.
- Others, at your direction or with your consent.
Where we engage a service provider we do so under a written agreement restricting the provider to processing personal data on our instructions and requiring appropriate security.
Sale, sharing and targeted advertising. We do not sell personal data for monetary consideration, and we do not share personal data for cross-context behavioral advertising, in each case as those terms are defined under United States state privacy laws. Should this change, we will amend this notice before the change takes effect and provide the opt-out mechanism the law requires, including a clear and conspicuous link on the Site. We do not disclose personal data to third parties for their own direct marketing purposes. We do not knowingly sell or share the personal data of any person under sixteen years of age.
7. How We Store Your Information
We retain personal data only for so long as it is required for the purposes described in this notice, after which it is deleted or de-identified. In determining the retention period we take into account the period necessary to respond to you and to deal with any follow-up; any legal, regulatory, tax, accounting or safety-reporting period that applies; whether a dispute or investigation is in progress or reasonably anticipated; and whether you have asked us to retain the data, as in the case of a subscription address, which is retained until you unsubscribe. Where a longer period is required by law or by a litigation hold, that period applies instead.
Security. We maintain administrative, technical and physical safeguards designed to protect personal data against accidental loss and against unauthorized access, use, alteration and disclosure, including access controls, encryption in transit, and secure hosting and development practices. No method of transmission over the internet and no method of electronic storage is entirely secure, and we cannot guarantee absolute security.
Children. The Site is intended for adults and is not directed at children. We do not knowingly collect personal data from any person under sixteen years of age. The Children’s Online Privacy Protection Act requires parental consent for the collection of personal data from children under thirteen. If you believe that a child has provided us with personal data, please contact us and we will delete it.
8. Additional Information on Your Rights
Subject to the conditions and exceptions provided by the applicable law, you may have the right to:
- obtain confirmation as to whether we process personal data concerning you, and to be informed of the categories processed, their sources, the purposes of processing and the categories of recipient;
- obtain a copy of that data, in a portable format where the law so provides;
- have inaccurate data corrected;
- have data erased;
- obtain a restriction of processing;
- object to processing carried out on the basis of legitimate interests;
- opt out of the sale or sharing of personal data, of targeted advertising, and of certain profiling;
- limit the use of sensitive personal data;
- withdraw consent at any time;
- appeal a decision taken by us in respect of a request, where the applicable law provides for an appeal; and
- not be subject to discriminatory treatment for having exercised a privacy right. We will not deny you a service, charge a different price, or provide a lower quality of service because you have exercised one.
We extend the substance of these choices to every person who contacts us, wherever resident, whether or not a statute so requires.
Making a request. Requests may be made by email to info@brainstorm-cell.com, marked “Privacy request”, or in writing to the address in section 10. We will acknowledge a request promptly and respond within the period prescribed by the applicable law, extending that period only where the law permits and notifying you before the first period expires. We are required to verify your identity before acting, which will ordinarily involve confirming control of the email address with which the data is associated; we request only what is necessary for that purpose. An authorized agent may submit a request on your behalf upon production of written permission signed by you, and we may nonetheless contact you to confirm it.
9. International Transfers
We operate internationally. Personal data provided through the Site is transferred to and processed in the United States, and may be transferred to other countries in which we or our service providers operate. Those countries may not provide a level of protection equivalent to that of your own.
Where personal data is transferred out of the European Economic Area, the United Kingdom or Switzerland, we do so on the basis of an adequacy decision where one applies, and otherwise under the European Commission’s Standard Contractual Clauses together with the UK International Data Transfer Addendum, supplemented by such additional measures as may be required. A copy of the safeguards relied upon may be requested from us.
10. Data Protection Queries - Contact Us
BrainStorm Cell Therapeutics Inc.
1325 Avenue of Americas, 28th Floor
New York, NY 10019
info@brainstorm-cell.com
If you are in the European Economic Area, the United Kingdom or Switzerland, you also have the right to lodge a complaint with your supervisory authority.
11. Changes to this Notice
We review this notice at least once every twelve months and amend it when our practices change. Amendments take effect upon posting unless the law provides otherwise or we state otherwise. The date at the head of this notice records when it was last amended. Where an amendment is material we will draw attention to it on the Site or, where required, notify you directly.
Effective 21 August 2026.
12. Additional Notice to United States Residents
This section supplements the preceding sections and applies only to residents of those states whose privacy legislation applies to us.
a. California. California residents may request the categories of personal data collected, the sources from which it was collected, the business purposes for which it was collected, and the categories of third party to which it was disclosed; a copy of the specific items collected; correction of inaccurate data; and deletion. California Civil Code section 1798.83 permits residents to request particulars of disclosures made to third parties for those parties’ own direct marketing purposes; as stated in section 6, we make no such disclosures. Requests may be submitted as described in section 8.
b. Other states. Residents of other states whose privacy legislation applies to us have the rights set out in section 8 to the extent that legislation provides them, including any right of appeal against a decision taken on a request.
c. Consumer health data. Residents of states with consumer health data legislation, including Washington and Nevada, may have additional rights in respect of health-related information, including the right to withdraw consent to its collection and sharing and the right to have it deleted. Section 2 describes our position on health information.
Part II - Legal Notes
1. Acceptance of these Terms
By accessing and browsing brainstorm-cell.com and any successor address (the “Site”), you accept these terms of use (the “Terms”) in full and without qualification, together with each document incorporated into them, including the Privacy and Cookie Notice at Part I above. If you do not accept them, you must not access or use the Site.
These Terms apply to your use of the Site from any device and over any network, and supersede any prior understanding between us in respect of the Site.
We may revise these Terms at any time by posting a revised version. A revision takes effect upon posting, and your continued use of the Site after it has been posted constitutes acceptance of it. You should review this page from time to time so that you are aware of the terms then in force.
2. Intellectual Property Rights
All right, title and interest in and to the Site and its contents - including text, graphics, images, illustrations, video, data, page design and the software by which the Site is delivered, together with all patents, copyrights, trademarks, trade names, service marks, trade dress, trade secrets and other intellectual property rights subsisting in them, and the goodwill attaching to them - are owned by or licensed to BrainStorm and are protected under the laws of the United States and other jurisdictions.
NurOwn® is a registered trademark of BrainStorm Cell Therapeutics Inc. Other names, logos and marks appearing on the Site may be the trademarks of their respective proprietors.
Nothing on the Site is to be construed as granting, by implication, estoppel or otherwise, any license or right in respect of any intellectual property of BrainStorm or of any third party.
You may view the Site and may download or print individual pages for your own personal and non-commercial reference, provided that every copyright and proprietary notice is preserved intact. Any other use requires our prior written permission. In particular, and save as expressly permitted here, you may not copy, reproduce, republish, distribute, display, perform, transmit, sublicense, sell, rent, lend, adapt, translate, modify or create derivative works from any part of the Site, nor make any commercial use of it, by any means. Images appearing on the Site may not be used separately from the pages in which they appear.
You may not adopt or use any name, mark or logo identical or confusingly similar to any of ours, and you must refrain from any act or omission liable to dilute or tarnish our goodwill. BrainStorm enforces its intellectual property rights.
3. Use of the Site
You are solely responsible for your use of the Site and for any use of it by any person acting on your behalf. You agree that you will not, and will not permit any other person to:
- breach these Terms or any other rule we publish in respect of the Site;
- use the Site for any unlawful purpose or in contravention of any applicable local, state, national or international law or regulation;
- interfere with, burden or disrupt the Site, its servers or any connected network, attempt to obtain unauthorized access to any of them, or probe or test their security;
- introduce any virus, malware or other harmful code;
- employ any robot, crawler, scraper or other automated means to access, collect or compile content from the Site, save for indexing by a search engine that observes our robots.txt file;
- post or transmit any content that is false, inaccurate, misleading, defamatory, obscene or unlawful;
- frame the Site or any part of it, or link to individual elements such as images separately from the pages in which they appear;
- present the Site or its contents in any manner that alters their content or design;
- impersonate any person or entity, or misrepresent your identity, employment or affiliation;
- collect or process personal data concerning other users without their consent; or
- link to the Site from any site containing unlawful, pornographic or discriminatory content.
Third-party sites. The Site contains links to websites and content operated by third parties. We neither operate nor monitor them. A link does not constitute an endorsement, nor a representation as to the accuracy, reliability or legality of anything appearing on the linked site. We accept no responsibility or liability for third-party sites, their content or their availability, and your use of them is at your own risk and subject to their own terms.
Your submissions. Save for personal data, which is handled under Part I, any communication, material, suggestion, idea, comment or feedback that you transmit to us through the Site is and will be treated as non-confidential and non-proprietary. We may use it for any purpose, including reproduction, disclosure, publication and the development of our programs, without obligation or compensation to you. You represent that anything you transmit is yours to transmit and infringes no third-party right. Please do not transmit confidential or proprietary information to us through the Site.
Territorial scope. The Site is intended for a general international audience. Information concerning our programs may be neither appropriate nor available in every country, and regulatory status differs between jurisdictions. We make no representation that the Site or its contents are appropriate or available for use in any particular location.
4. Exclusions and Limitation of Liability
No medical advice. The Site does not provide medical advice. Nothing on it is a substitute for professional medical advice, diagnosis or treatment, and nothing on it creates a physician-patient relationship. You should always seek the advice of your physician or another qualified health provider in respect of a medical condition or treatment, and you should never disregard professional medical advice, or delay in seeking it, by reason of anything appearing on the Site.
Investigational status. Our product candidates, including autologous MSC-NTF cells (NurOwn, debamestrocel), are investigational. They have not been approved by the U.S. Food and Drug Administration or by any other regulatory authority, and their safety and efficacy have not been established. Information concerning our product candidates is provided for informational purposes and is not promotional; it constitutes neither an offer of treatment nor a representation that any product candidate is safe or effective for any use. Information concerning clinical trials is provided as a general description; it is not an invitation to enroll and does not describe eligibility, which is determined by the investigators at participating sites in accordance with the protocol.
Forward-looking statements. The Site contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, made in reliance upon the safe harbor for which that Act provides. Such statements are not statements of historical fact and frequently employ words such as “expects”, “anticipates”, “plans”, “intends”, “believes”, “may” and “will”. They reflect our expectations as at the date on which they are made and are subject to risks, uncertainties and assumptions, many of which lie outside our control, including the outcome and timing of clinical trials and regulatory reviews, the availability of funding, manufacturing and supply matters, competition, intellectual property, and the risk factors described in our filings with the U.S. Securities and Exchange Commission. Actual results may differ materially. We undertake no obligation to update any forward-looking statement, save as required by law, and information on the Site may not be current.
No offer of securities. Nothing on the Site constitutes an offer to sell, or a solicitation of an offer to buy, any security, nor investment, financial, tax or legal advice, nor a recommendation in respect of any transaction in our securities. Any offer of securities will be made solely by means of a prospectus or offering document satisfying the requirements of the applicable securities laws. Financial and corporate information appearing on the Site, including any share price, is provided for convenience and may be delayed, incomplete or inaccurate. Where information on the Site differs from information contained in a document we have filed with or furnished to the U.S. Securities and Exchange Commission, the filed document governs. Our filings are available on EDGAR at sec.gov. You should not rely upon the Site in reaching any decision concerning our securities. A reference on the Site to a third party’s report, analysis or estimate does not constitute our endorsement or adoption of it.
Availability. We may alter the layout, design, contents, features and functionality of the Site at any time and without notice, and may add to, modify, suspend or withdraw any part of it. We may introduce further functionality - including accounts, subscriptions, alerts, forms, webcasts and interactive features - and these Terms will apply to that functionality as introduced. The availability of the Site depends upon software, hardware and networks, some supplied by third parties, none of which is free from fault, and we do not warrant that the Site will be available or accessible at all times. We may suspend or discontinue the Site, in whole or in part and whether temporarily or permanently; we will endeavor to give reasonable notice before a permanent discontinuation but are not obliged to do so, and we accept no liability in respect of any discontinuation or any resulting loss of data. We take care over the accuracy of what we publish; if you believe that anything on the Site is incorrect, please tell us using the details in section 7.
Disclaimer of warranties. THE SITE AND ALL CONTENT APPEARING ON IT ARE PROVIDED ON AN “AS IS” AND “AS AVAILABLE” BASIS. TO THE MAXIMUM EXTENT PERMITTED BY LAW WE DISCLAIM ALL WARRANTIES AND REPRESENTATIONS OF EVERY KIND, WHETHER EXPRESS, IMPLIED OR STATUTORY, INCLUDING ANY WARRANTY OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, QUALITY, NON-INFRINGEMENT, TITLE, COMPATIBILITY, PERFORMANCE, SECURITY, ACCURACY OR COMPLETENESS. WE DO NOT WARRANT THAT THE SITE WILL OPERATE UNINTERRUPTED OR ERROR-FREE, THAT DEFECTS WILL BE CORRECTED, OR THAT THE SITE OR THE SERVERS BY WHICH IT IS MADE AVAILABLE ARE FREE OF VIRUSES OR OTHER HARMFUL COMPONENTS. YOU USE THE SITE ENTIRELY AT YOUR OWN RISK.
Limitation of liability. TO THE MAXIMUM EXTENT PERMITTED BY LAW, NEITHER BRAINSTORM NOR ITS OFFICERS, DIRECTORS, SHAREHOLDERS, EMPLOYEES, SUBCONTRACTORS, AFFILIATES OR AGENTS WILL BE LIABLE FOR ANY DIRECT, INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL, EXEMPLARY OR PUNITIVE DAMAGE, NOR FOR ANY LOSS OF PROFIT, REVENUE, DATA, GOODWILL OR BUSINESS OPPORTUNITY, NOR FOR ANY COST OR EXPENSE, WHETHER IN CONTRACT, TORT, NEGLIGENCE, STRICT LIABILITY OR UPON ANY OTHER BASIS, ARISING OUT OF OR IN CONNECTION WITH (a) YOUR USE OF, OR INABILITY TO USE, THE SITE; (b) ANY FAILURE, ERROR, INTERRUPTION, DEFECT, DELAY OR BREAKDOWN IN THE SITE; (c) ANY VIRUS OR OTHER HARMFUL CODE TRANSMITTED THROUGH THE SITE; (d) YOUR RELIANCE UPON ANY CONTENT APPEARING ON THE SITE; (e) ANY THIRD-PARTY SITE OR CONTENT LINKED FROM THE SITE; OR (f) ANY UNAUTHORIZED ACCESS TO OR ALTERATION OF YOUR TRANSMISSIONS OR DATA, EVEN IF WE HAVE BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGE.
Nothing in these Terms excludes or limits any liability that cannot lawfully be excluded or limited, including liability for death or personal injury caused by negligence, or for fraud or fraudulent misrepresentation. Certain jurisdictions do not permit the exclusion or limitation of particular warranties or damages, and in those jurisdictions the exclusions and limitations above apply only so far as the law allows.
Indemnity. You agree to indemnify, defend and hold harmless BrainStorm and its officers, directors, shareholders, employees, subcontractors, affiliates and agents against any claim, demand, damage, loss, cost or expense, including reasonable legal fees, arising out of or in connection with your breach of these Terms, your misuse of the Site, or your violation of any law or of any third-party right. We reserve the right to assume the exclusive defense of any matter otherwise subject to indemnification by you, at your expense, and you agree to cooperate with us in that defense.
5. Data Protection and Privacy
Part I of this page is our Privacy and Cookie Notice. It explains how we handle personal data collected through the Site and is incorporated into these Terms by reference. Our accessibility statement sets out the standard to which we build the Site, what has been tested, and how to report a barrier.
6. General
Governing law. These Terms, and any dispute or claim arising out of or in connection with them or with the Site, are governed by and are to be interpreted in accordance with the laws of the State of Delaware, United States, without regard to its conflict of laws principles and without regard to the United Nations Convention on Contracts for the International Sale of Goods.
Jurisdiction. Any proceeding arising out of or in connection with these Terms or the Site is to be brought exclusively in the state or federal courts situated in the State of Delaware, and you consent to the personal jurisdiction of those courts and waive any objection to venue in them.
Consumers. If you are a consumer resident in the European Economic Area or the United Kingdom, nothing in these Terms deprives you of the protection of the mandatory law of your country of residence, nor of any right to bring proceedings in that country.
Severability. If any provision of these Terms is held to be illegal, invalid or unenforceable, that provision is to be enforced to the maximum extent permitted and the remaining provisions continue in full force and effect.
Waiver. Our failure to enforce any provision does not constitute a waiver of that provision or of any other.
Assignment. You may not assign or transfer these Terms. We may assign them to an affiliate or in connection with a merger, acquisition or sale of assets.
Entire agreement. These Terms, together with the Privacy and Cookie Notice and any notice published on the Site, constitute the entire agreement between you and us in respect of the Site.
Third parties. Save for the persons indemnified under section 4, these Terms confer no right upon any third party.
Survival. Sections 2, 3, 4 and 6 survive any termination of your access to the Site.
7. General
Questions concerning these Terms, or concerning anything appearing on the Site, may be directed to:
BrainStorm Cell Therapeutics Inc.
1325 Avenue of Americas, 28th Floor
New York, NY 10019
info@brainstorm-cell.com
The contact page identifies the appropriate route for particular categories of inquiry.
Effective 21 August 2026.